Intravenous versus oral vinorelbine plus capecitabine as second-line treatment in advanced breast cancer patients. A retrospective comparison of two consecutive phase II studies.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples